Immediate Impact
2 from Science/Nature 84 standout
Citing Papers
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Works of C M Busst being referenced
A new device for ambulatory cough recording
1994
Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation.
1992
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C M Busst | 545 | 366 | 242 | 250 | 20 | 685 | |
| H. W. Fritts | 392 | 85 | 148 | 127 | 26 | 690 | |
| Hans U. Wessel | 368 | 411 | 241 | 238 | 31 | 614 | |
| Carl Mottram | 434 | 372 | 253 | 226 | 21 | 818 | |
| Steven K. Goldberg | 357 | 181 | 146 | 72 | 19 | 718 | |
| Weidman Wh | 275 | 326 | 214 | 237 | 22 | 584 | |
| Jeryl Huckaby | 534 | 157 | 233 | 125 | 12 | 670 | |
| Aaron Himmelstein | 332 | 94 | 192 | 292 | 20 | 675 | |
| H. Werner | 253 | 147 | 128 | 93 | 29 | 575 | |
| L. Görnandt | 323 | 249 | 152 | 399 | 16 | 753 | |
| Alan G. Magee | 572 | 452 | 253 | 421 | 34 | 835 |
All Works
Loading papers...